- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
AstraZeneca
Market Cap: UK£180.7b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£116.50
7D
-2.7%
1Y
-2.2%
Chugai Pharmaceutical
Market Cap: JP¥10.7t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥6,388.00
7D
-7.1%
1Y
-3.9%
Orion Oyj
Market Cap: €11.1b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€79.20
7D
-1.6%
1Y
19.7%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥46.9b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥103.05
7D
-7.2%
1Y
-10.4%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€57.70
7D
-3.7%
1Y
-2.9%
Xiamen Amoytop Biotech
Market Cap: CN¥22.0b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥54.67
7D
-1.3%
1Y
-34.1%
PharmaResearch
Market Cap: ₩3.8t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩349,500.00
7D
-8.3%
1Y
-46.5%